Skip to main content

Market Overview

50 Stocks Moving In Thursday's Mid-Day Session

Share:

Gainers

  • Scopus BioPharma Inc. (NASDAQ: SCPS) shares jumped 500% to $35.52. Scopus BioPharma’s filing showed registration for 500,000 share common stock offering. Scopus Biopharma shares gained around 8% on Wednesday after the company priced its IPO at $5.5 per share.
  • MingZhu Logistics Holdings Ltd (NASDAQ: YGMZ) shares climbed 205% to $12.22 .
  • Nxt-ID, Inc. (NASDAQ: NXTD) climbed 94.3% to $1.7950 after jumping around 90% on Wednesday.
  • Oriental Culture Holding Ltd (NASDAQ: OCG) gained 90.8% to $11.64 as a potential post IPO volatility. Oriental Cultural, on Tuesday, priced its IPO at $4 per share.
  • Wunong Net Technology Company Limited (NASDAQ: WNW) shares gained 80.1% to $117.22 after jumping 440% on Wednesday. The company, on Tuesday, priced its IPO at $5 per share.
  • Vivos Therapeutics, Inc. (NASDAQ: VVOS) climbed 37.4% to $9.31. Vivos Therapeutics, earlier during the month, priced its IPO at $6 a share.
  • Jupiter Wellness, Inc. (NASDAQ: JUPW) gained 36.1% to $7.20 after climbing 19% on Wednesday. Jupiter Wellness, recently reported the acquisition of SRM Entertainment, LTD from Vinco Ventures, Inc.
  • Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 30% to $4.79 after the company issued regulatory update for IV Tramadol.
  • Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) surged 30% to $4.2916.
  • Upstart Holdings, Inc. (NASDAQ: UPST) gained 24% to $36.53. Upstart Holdings shares surged 47% on Wednesday after the company priced its IPO at $20 per share.
  • Evolus, Inc. (NASDAQ: EOLS) rose 22.6% to $4.50 after the company issued an update on United States International Trade Commission (ITC) case.
  • Marathon Patent Group, Inc.. (NASDAQ: MARA) gained 22.6% to $10.09 after surging 16% on Wednesday.
  • PainReform Ltd. (NASDAQ: PRFX) jumped 20% to $5.20.
  • Rite Aid Corporation (NYSE: RAD) climbed 18% to $20.18 after the company reported better-than-expected Q3 results and issued strong FY21 guidance .
  • Bit Digital, Inc. (NASDAQ: BTBT) shares climbed 17.8% to $5.95 following an 18% decline on Wednesday. Bit Digital, earlier during the month, highlighted completion of acquisition of $13,902,742 worth of bitcoin miners with total hash rate of 1,003.5 Ph/s.
  • TuanChe Limited (NASDAQ: TC) surged 17.8% to $5.03.
  • MiMedx Group, Inc. (NASDAQ: MDXG) surged 16.4% to $9.11. MiMedx Group shares jumped 19% on Wednesday after Prescience Point Capital Management, a company shareholder, gave bullish commentary on the stock and issued a $31 price target.
  • Cogent Biosciences, Inc. (NASDAQ: COGT) gained 16.3% to $12.65. SVB Leerink, on Wednesday, initiated coverage on Cogent Biosciences with an Outperform rating and a price target of $20.
  • Canaan Inc. (NASDAQ: CAN) rose 16.1% to $4.41 after gaining around 7% on Wednesday.
  • fuboTV Inc. (NASDAQ: FUBO) gained 15.8% to $34.41.
  • Drive Shack Inc. (NASDAQ: DS) surged 14.8% to $3.25. Drive Shack is scheduled to reopen its Orlando venue on December 18th.
  • Skillful Craftsman Education Technology Limited (NASDAQ: EDTK) rose 14.7% to $3.3211.
  • Ondas Holdings Inc. (NASDAQ: ONDS) shares jumped 14.5% to $7.10.
  • Enlivex Therapeutics Ltd. (NASDAQ: ENLV) rose 10.4% to $11.30. Enlivex, earlier during the month, reported issuance of new Chinese patent covering allocetra immunotherapy.
  • 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 8.6% to $0.82. OrbiMed Israel BioFund GP Limited Partnership reported a 16% stake in 9 Meters Biopharma.
  • Accenture plc (NYSE: ACN) rose 8.5% to $268.55 after the company reported upbeat Q1 results and issued strong Q2 sales forecast.
  • Jabil Inc (NYSE: JBL) climbed 6.6% to $43.75 after the company posted upbeat Q1 results and issued strong Q2 earnings outlook.
  • Lennar Corporation (NYSE: LEN) rose 6% to $78.77 following upbeat quarterly earnings.
  • Roku, Inc. (NASDAQ: ROKU) rose 4.3% to $339.79. Roku is partnering with AT&T’s subscription video-on-demand streaming service HBO Max starting Thursday.

Check out these big penny stock gainers and losers

Losers

  • Triterras Inc (NASDAQ: TRIT) shares dipped 36.5% to $8.39 after confirming it informed a statutory demand for payment was made to Antanium Resources in Singapore. Triterras said in a regulatory filing it was informed that a statutory demand for payment from Antainium Resources (formerly known as Rhodium Resources) was filed by a creditor of Rhodium on Dec. 1.
  • BioCardia Inc (NASDAQ: BCDA) fell 25.5% to $4.3189. BioCardia disclosed positive DSMB review and recommendation to continue Phase III pivotal CardiAMP heart failure study as designed. BioCardia recently reported a 1.789 million share registered direct offering priced at $4.75 per share.
  • CooTek (Cayman) Inc. (NYSE: CTK) shares dipped 22.5% to $3.1473. CooTek, on Wednesday, reported a mixed securities shelf offering.
  • Dragon Victory International Limited (NASDAQ: LYL) dropped 19.5% to $2.2292.
  • Mediaco Holding Inc (NASDAQ: MDIA) fell 19.2% to $2.91 after climbing around 35% on Wednesday.
  • SCYNEXIS, Inc. (NASDAQ: SCYX) fell 18.3% to $5.99 after the company announced the launch of $50 million common stock and warrant offering.
  • Uxin Limited (NASDAQ: UXIN) fell 17.3% to $1.1582 after reporting Q2 results.
  • Standard Motor Products, Inc. (NYSE: SMP) shares dropped 15.8% to $45.39.
  • Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) dipped 15.7% to $3.52 as the company issued regulatory update on Zygel in Fragile X syndrome.
  • Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI) dropped 14% to $8.90. FatBoy Capital, on Wednesday, disclosed a 6.9% active stake in the company.
  • Surface Oncology, Inc. (NASDAQ: SURF) fell 13.7% to $8.60. Surface Oncology announced an agreement for GlaxoSmithKline to exclusively license worldwide development and commercial rights to its preclinical program SRF813, an inhibitory protein expressed on natural killer cells and T cells, for an $85-million upfront payment.
  • Herman Miller, Inc. (NASDAQ: MLHR) dropped 13.2% to $35.20 after reporting Q2 results.
  • R. R. Donnelley & Sons Company (NASDAQ: RRD) fell 12.8% to $1.8220 after climbing around 19% on Wednesday. R.R. Donnelley, last week, reported a vaccination distribution toolkit to support marketing and operations for pending COVID-19 vaccine.
  • Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) dropped 12.6% to $40.25 as the company reported pricing of public offering of common stock.
  • Atossa Therapeutics, Inc. (NASDAQ: ATOS) shares fell 9.8% to $0.8659 after gaining around 10% on Wednesday. Atossa Therapeutics, last week, priced a $20 million underwritten public offering.
  • Qutoutiao Inc. (NASDAQ: QTT) fell 9.7% to $2.2582 following Q3 results.
  • CureVac N.V. (NASDAQ: CVAC) fell 9% to $105.75. CureVac recently announced the commencement of its global pivotal Phase2b/3 trial for its Covid-19 vaccine candidate CVnCoV.
  • Apollo Endosurgery, Inc. (NASDAQ: APEN) shares fell 7.8% to $3.66. Apollo Endosurgery, on Wednesday, announced it received FDA clearance for the X-Tack Endoscopic HeliX Tacking System.
  • Heat Biologics, Inc. (NASDAQ: HTBX) fell 6.6% to $5.51. Heat Biologics shares climbed around 10% on Wednesday after the company announced completion of ZVX-60 vaccine cell line for COVID-19.
  • Allied Esports Entertainment Inc. (NASDAQ: AESE) fell 5.3% to $1.5150. Allied Esports, on Wednesday, launches 24-hour cross-channel content strategy on Twitch.
  • Aethlon Medical, Inc. (NASDAQ: AEMD) fell 5.1% to $2.1450. Aethlon Medical shares jumped over 40% on Wednesday after the company treated the first patient in its first-in-human Early Feasibility Study of the HEMOPURIFIER.
 

Related Articles (ACN + AEMD)

View Comments and Join the Discussion!

Posted-In: News Penny Stocks Short Sellers Small Cap Intraday Update Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com